Isoliquiritigenin: a potential drug candidate for the management of erectile dysfunction.

Queen SaikiaKamal AdhikariAiry SanjeevAjit HazarikaKishore Sarma

Published in: The Journal of pharmacy and pharmacology (2024)

The results showed that ISL is equally potent as SDF in terms of binding affinity, specific pharmacological properties, and modulating sexual behavior.

Keyphrases

binding protein
signaling pathway
mental health
anti inflammatory
human health
emergency department
risk assessment
transcription factor